Edges in Network
Network | GSE16446_egf1520 - GSE16446 - SiGN-BN HC+Bootstrap |
Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
Node | MAP3K4 |
Upstream (Parents) |
---|
(<<) APH1B → MAP3K4 |
(<<) BMP2 → MAP3K4 |
(<<) CYR61 → MAP3K4 |
(<<) DUSP7 → MAP3K4 |
(<<) GLRX → MAP3K4 |
(<<) HEY1 → MAP3K4 |
(<<) HSPA5 → MAP3K4 |
(<<) KPNA1 → MAP3K4 |
(<<) MLX → MAP3K4 |
(<<) NDOR1 → MAP3K4 |
(<<) RCAN1 → MAP3K4 |
(<<) RHOB → MAP3K4 |
(<<) SFN → MAP3K4 |
(<<) SH3GLB1 → MAP3K4 |
(<<) SH3KBP1 → MAP3K4 |
(<<) SOX9 → MAP3K4 |
(<<) TIMP2 → MAP3K4 |
(<<) TINF2 → MAP3K4 |
(<<) TSPO → MAP3K4 |
Downstream (Children) |
---|
MAP3K4 → ARHGEF4 (>>) |
MAP3K4 → BCL2 (>>) |
MAP3K4 → CHAC1 (>>) |
MAP3K4 → FOXC2 (>>) |
MAP3K4 → GNAL (>>) |
MAP3K4 → GPNMB (>>) |
MAP3K4 → HDAC4 (>>) |
MAP3K4 → INSR (>>) |
MAP3K4 → IQSEC2 (>>) |
MAP3K4 → MAPK13 (>>) |
MAP3K4 → NCOR1 (>>) |
MAP3K4 → PARD6G (>>) |
MAP3K4 → PIK3R3 (>>) |
MAP3K4 → PLD1 (>>) |
MAP3K4 → SDK2 (>>) |
MAP3K4 → SMAD2 (>>) |
MAP3K4 → SYNJ2 (>>) |
MAP3K4 → TAF9 (>>) |
MAP3K4 → UBE2I (>>) |